Scilex Holding (SCLXW) Return on Assets (2021 - 2026)
Scilex Holding (SCLXW) recorded quarterly Return on Assets of 0.01% in Q1 2026, down 2.39% quarter-over-quarter from 0.01% in Q4 2025, and little changed on a YoY basis from 0.01% in Q1 2025.
Scilex Holding (SCLXW) Return on Assets (2021 - 2026) Analysis & Trends
Scilex Holding's Return on Assets history runs 6 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
- Return on Assets was 0.01% for Q1 2026 at Scilex Holding, down from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2022 to a low of 0.02% in Q3 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
- The sharpest annual moves came in 2023 and 2024: Return on Assets slipped 1 bps in 2023, then gained 1 bps in 2024.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then slumped by 406 bps to 0.01% in 2023, then surged by 40 bps to 0.01% in 2024, then plunged by 55 bps to 0.01% in 2025, then dropped by 2 bps to 0.01% in 2026.
- The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 0.00% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.00% |
| 10 | Scilex Holding | - | - | 4.15 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |